Retraction Note: Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Retraction Notice: Comprehensive Multi-Omics Investigation of Genomic, Epigenomic, and Transcriptomic Profiles for Identifying Molecular Subtypes and Key Genes in Lung Adenocarcinoma

  • By

  • Yue Zhao

  • Yakun Gao

  • Xiaodong Xu

  • Jiwu Zhou

  • He Wang

  • July 9, 2026

Share

  • 1

    The article titled 'Comprehensive Multi-Omics Investigation of Genomic, Epigenomic, and Transcriptomic Profiles for Identifying Molecular Subtypes and Key Genes in Lung Adenocarcinoma' has been retrac

  • 2

    Concerns were raised regarding data similarities in figures, specifically in Fig. 13A and Fig. 13B.

  • 3

    The detected similarities involved multiple panels within the figures, raising questions about data integrity.

  • 4

    The authors did not respond to the concerns raised by the editors or the publisher.

  • 5

    Due to the lack of response and confidence in the data, the editors decided to retract the article.

Original Source(s)

Retraction Note: Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma

  • by Yue Zhao, Yakun Gao, Xiaodong Xu, Jiwu Zhou, He Wang

  • July 9, 2026

Related Content

CAR T Before Surgery Improves Glioblastoma Control in Mice

Study finds that tumor resection creates a more immunosuppressive environment and that earlier CAR T cell treatment prolongs survival

  • September 7, 2026

  • 3 min
Cost-Effectiveness of Electronic Patient-Reported Outcome Measure Interventions in Cancer: Systematic Review and Parameter Extraction for Economic Modeling

Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

The goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer.

  • by

  • September 4, 2026

  • 4 min